NCT04765007

Brief Summary

Psychological impairments have a significant role in management and coping of pain in patients with orofacial pain disorders. The response of this kind of pathologies to topical or systemic medications is not predictable and mindfulness breathing and relaxation techniques could present good results since it help patients to accept their problem and to cope it. In consequence, the present study is aimed to evaluate the efficacy of a mindfulness therapy program in management of chronic orofacial pain.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

February 21, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

May 4, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 7, 2021

Completed
Last Updated

May 3, 2021

Status Verified

April 1, 2021

Enrollment Period

Same day

First QC Date

February 2, 2021

Last Update Submit

April 28, 2021

Conditions

Keywords

mindfulnesschronic painorofacial pain

Outcome Measures

Primary Outcomes (24)

  • orofacial pain intensity

    mean of orofacial pain in the last seven days evaluated with Numeric Pain Rating Scale (NPRS). A scale from 0 to 10, where 0 is considered as no pain and 10 as the worst pain.

    pre-intervention

  • orofacial pain intensity

    mean of orofacial pain in the last seven days evaluated with Numeric Pain Rating Scale (NPRS). A scale from 0 to 10, where 0 is considered as no pain and 10 as the worst pain

    8 weeks

  • orofacial pain intensity

    mean of orofacial pain in the last seven daysevaluated with Numeric Pain Rating Scale (NPRS). A scale from 0 to 10, where 0 is considered as no pain and 10 as the worst pain

    5 months

  • Symptoms of temporomandibular disorders

    Evaluation of the presence or absence of symptoms caused by temporomandibular disorders and their severity evaluated with Fonseca Anamnestic Index (FAI).

    pre-intervention

  • Symptoms of temporomandibular disorders

    Evaluation of the presence or absence of symptoms caused by temporomandibular disorders and their severity evaluated with Fonseca Anamnestic Index (FAI).

    8 weeks

  • Symptoms of temporomandibular disorders

    Evaluation of the presence or absence of symptoms caused by temporomandibular disorders and their severity evaluated with Fonseca Anamnestic Index (FAI).

    5 months

  • Catastrophization of pain

    Evaluation of pain catastrophization through Pain Catastrophizing Scale (PCS). The PCS is a 13-item self-report questionnaire. Each item is scored from 0 (not at all) to 4 (always), and scores range from 0 to 52.

    pre-intervention

  • Catastrophization of pain

    Evaluation of pain catastrophization through Pain Catastrophizing Scale (PCS). The PCS is a 13-item self-report questionnaire. Each item is scored from 0 (not at all) to 4 (always), and scores range from 0 to 52.

    8 weeks

  • Catastrophization of pain

    Evaluation of pain catastrophization through Pain Catastrophizing Scale (PCS). The PCS is a 13-item self-report questionnaire. Each item is scored from 0 (not at all) to 4 (always), and scores range from 0 to 52.

    5 months

  • Kinesiophobia

    Assessment of fear of movement in temporomandibular disorders evaluated with Tampa Scale of Kinesiophobia for Temporomandibular Disroders (TSK-TMD). The TSK-TMD is an 18-item self-report questionnaire, where the degree of agreement with each of the presented statements is recorded on a response scale from 1 (completely disagree) to 4 (completely agree). The scores are summed to provide a total score, with higher values reflecting greater kinesiophobia.

    pre-intervention

  • Kinesiophobia

    Assessment of fear of movement in temporomandibular disorders evaluated with Tampa Scale of Kinesiophobia for Temporomandibular Disroders (TSK-TMD). The TSK-TMD is an 18-item self-report questionnaire, where the degree of agreement with each of the presented statements is recorded on a response scale from 1 (completely disagree) to 4 (completely agree). The scores are summed to provide a total score, with higher values reflecting greater kinesiophobia.

    8 weeks

  • Kinesiophobia

    Assessment of fear of movement in temporomandibular disorders evaluated with Tampa Scale of Kinesiophobia for Temporomandibular Disroders (TSK-TMD). The TSK-TMD is an 18-item self-report questionnaire, where the degree of agreement with each of the presented statements is recorded on a response scale from 1 (completely disagree) to 4 (completely agree). The scores are summed to provide a total score, with higher values reflecting greater kinesiophobia.

    5 months

  • Impact of headache

    Evaluation of the impact caused by headache using the Headache Impact Test (HIT-6)

    pre-intervention

  • Impact of headache

    Evaluation of the impact caused by headache using the Headache Impact Test (HIT-6)

    8 weeks

  • Impact of headache

    Evaluation of the impact caused by headache using the Headache Impact Test (HIT-6)

    5 months

  • Sleep quality

    Assessment of sleep quality with the Medical Outcomes Study Sleep Scale (MOS-SS). the MOS-SS is a self-administered questionnaire comprised of 12 items in six different domains or sub-scales.

    pre-intervention

  • Sleep quality

    Assessment of sleep quality with the Medical Outcomes Study Sleep Scale (MOS-SS). the MOS-SS is a self-administered questionnaire comprised of 12 items in six different domains or sub-scales.

    8 weeks

  • Sleep quality

    Assessment of sleep quality with the Medical Outcomes Study Sleep Scale (MOS-SS). the MOS-SS is a self-administered questionnaire comprised of 12 items in six different domains or sub-scales.

    5 months

  • Dizziness-related disability

    Evaluation of dizziness-related disability through Dizziness Handicap Inventory (DHI)

    pre-intervention

  • Dizziness-related disability

    Evaluation of dizziness-related disability through Dizziness Handicap Inventory (DHI)

    8 weeks

  • Dizziness-related disability

    Evaluation of dizziness-related disability through Dizziness Handicap Inventory (DHI)

    5 months

  • Neck pain-related disability

    Assessment of neck pain-related disability with Neck Disability Index (NDI)

    pre-intervention

  • Neck pain-related disability

    Assessment of neck pain-related disability with Neck Disability Index (NDI)

    8 weeks

  • Neck pain-related disability

    Assessment of neck pain-related disability with Neck Disability Index (NDI)

    5 months

Study Arms (2)

Mindfulness group

EXPERIMENTAL

This arm will be treated with a mindfulness-based stress reduction therapy.

Other: mindfulness-based stress reduction

Control group

OTHER

This arm will be treated with a minimal intervention.

Other: Minimal intervention

Interventions

Eight sessions of two hours and a half, one day per week during eight weeks. In addition, patients will perform a day of intensive silent practice of 6-8 hours of duration. The content of each session balances three activities: the presentation of a topic, moments of dialogue and group exploration (using appreciative inquiry) and a Mindfulness practice. The sessions will take place in online format, through the google meet application

Also known as: MBSR
Mindfulness group

A guided meditation program of eight weeks of duration will be provided to the patients and they will be informed about the procedure and the beneficial effects of the therapy.

Control group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed of orofacial chronic pain by a physician.

You may not qualify if:

  • Pain with oncologic origin
  • Severe mental disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Chronic PainFacial Pain

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Central Study Contacts

Yolanda Castellote

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

February 2, 2021

First Posted

February 21, 2021

Study Start

May 4, 2021

Primary Completion

May 4, 2021

Study Completion

October 7, 2021

Last Updated

May 3, 2021

Record last verified: 2021-04